Longevity & Healthspan and Your Genetics
Reviewed by the ExomeDNA Science Team.
This page contains general information only. For personal health decisions, consult a qualified clinician.
Longevity & Healthspan reflects the genetic factors associated with living a longer, healthier life — spanning healthy aging, parental lifespan, and biological resilience. Your ExomeDNA result draws on a multivariate genomic analysis that identified shared genetic signals across multiple longevity endpoints simultaneously. Below: the genes involved, what the research shows, and science-backed steps to support a longer healthspan.
What is Longevity & Healthspan?
Longevity refers to the length of a person's life. Healthspan is a related but distinct concept — it captures how many of those years are spent in good health, free of major disease or functional decline. A person can live a long time while experiencing many years of illness; healthspan focuses specifically on the quality and vitality of those extra years.
From a genetics standpoint, longevity and healthspan are complex, polygenic traits. No single gene determines whether someone lives to 100 in good health. Instead, hundreds of common variants across the genome each contribute modestly, and their collective signal — measured through genome-wide association studies (GWAS) — gives a probabilistic picture of an individual's genetic starting point for healthy aging.
Environmental and behavioral factors — what you eat, how much you move, whether you smoke, the quality of your sleep, the strength of your social connections — interact with this genetic backdrop to produce actual lifespan outcomes. Genetics is one piece of a much larger picture, and it is a piece you can contextualize and act on.
The genetics behind Longevity & Healthspan
Your ExomeDNA Longevity & Healthspan score is derived from a multivariate GWAS that combined data across three related phenotypes: healthspan, parental lifespan, and longevity (survival to extreme age). By analyzing these endpoints together, the study identified genetic loci that influence healthy aging across multiple dimensions simultaneously — a more comprehensive lens than any single longevity measure could provide.
Five genes are authorized in your result: FOXO3, APOE, CHRNA3, CHRNA5, and ATXN2. Each connects to longevity biology through a distinct mechanism.
FOXO3 — the most replicated human longevity gene
FOXO3 encodes the forkhead box O3 transcription factor, a master regulator of cellular stress response, metabolism, and lifespan. It is the most consistently replicated human longevity gene identified to date, with protective variants over-represented in centenarians across at least six independent populations: Japanese, German, American, Chinese, Italian, and Ashkenazi Jewish cohorts.
FOXO3 acts as a molecular sensor that translates the body's metabolic and stress state into a coordinated gene expression program supporting longevity. When energy is scarce — during caloric restriction, fasting, or sustained aerobic exercise — the energy-sensing enzyme AMPK activates FOXO3. The NAD+-dependent deacetylase SIRT1, itself upregulated during caloric restriction, provides a second activation signal. Oxidative stress and ketone bodies also engage FOXO3 activity.
Once activated, FOXO3 drives expression of a suite of pro-longevity target genes: MnSOD (mitochondrial antioxidant defense), GADD45 (DNA damage repair), Beclin-1 (autophagy initiation), BNIP3 (mitophagy — clearance of damaged mitochondria), and CDKN1A (cell cycle arrest that prevents damaged cells from replicating). Collectively, these targets represent the major cellular pathways implicated in slowing biological aging: antioxidant defense, DNA repair, autophagy, and mitochondrial quality control.
The FOXO3 variants most strongly associated with longevity — including rs2764264 and rs13220810 — appear to support more robust FOXO3 activity under stress conditions, linking caloric restriction biology, exercise physiology, and stress resilience into a single genomic hub.
APOE — the strongest single-gene determinant of differential aging trajectory
APOE encodes apolipoprotein E, a lipid transport protein with three common isoforms: E2, E3, and E4. These isoforms have opposite effects on longevity. The E4 isoform increases risk for Alzheimer's disease and cardiovascular disease and is associated with a shorter average lifespan. The E2 isoform is associated with greater longevity, lower Alzheimer's risk, and more efficient lipid clearance — making it the protective end of the APOE spectrum. E3, the most common isoform, represents the population baseline.
Among common genetic variants, APOE genotype represents the single strongest known determinant of differential aging trajectory at the population level. The beneficial framing of APOE in a longevity context centers on the E2 variant: individuals carrying E2 alleles show population-level evidence for longer healthspan and reduced burden of age-related neurodegeneration and cardiovascular disease.
CHRNA3 and CHRNA5 — the smoking genes that affect how long you live
CHRNA3 and CHRNA5 encode the alpha-3 and alpha-5 subunits of the nicotinic acetylcholine receptor, a protein complex central to nicotine's effect on the brain's reward circuitry. Variants at this 15q25 chromosomal locus are among the strongest known genetic determinants of nicotine dependence and smoking behavior.
Their presence in a longevity GWAS is not coincidental — it reflects a direct, mechanistic link between smoking susceptibility genetics and lifespan. Nicotine addiction genetics reduces healthspan through smoking-related disease: lung cancer, COPD, cardiovascular disease, and accelerated biological aging. Protective variants at CHRNA3 and CHRNA5 support healthspan by reducing genetic susceptibility to nicotine dependence, thereby reducing the probability of sustained smoking behavior and its downstream consequences on lifespan.
ATXN2 — cellular stress resilience
ATXN2 encodes ataxin-2, an RNA-binding protein involved in stress granule assembly and RNA homeostasis. In neurons particularly, normal ataxin-2 function supports the cell's ability to manage translational stress — the cellular response to protein synthesis demands under adverse conditions. Variants at ATXN2 contribute to healthspan variation through their effects on cellular stress resilience, particularly in the nervous system.
What the research says
Research base: Moderate.
The primary study underlying your result is a 2020 multivariate genomic scan of human aging (PMID 32678081, Timmers et al., Nature Communications). The study applied a multivariate GWAS framework — combining healthspan, parental lifespan, and longevity as correlated outcomes — to identify 10 independent genomic loci associated with healthy aging across all three measures simultaneously. This design improves statistical power by leveraging shared genetic architecture across related aging phenotypes, rather than treating each endpoint in isolation.
Key findings from PMID 32678081:
- The multivariate approach identified novel longevity loci not detected by single-trait GWAS of lifespan or healthspan alone, including signals implicating haem metabolism pathways in human aging.
- FOXO3, APOE, CHRNA3/CHRNA5, and ATXN2 emerged among loci with genome-wide or near-genome-wide significance in the combined analysis.
- Mendelian randomization analyses within the study supported a causal role for smoking-related genetic variants (including CHRNA3/5) on lifespan reduction.
- The genetic signals for healthspan and parental longevity showed substantial genetic correlation with each other, validating the multivariate analytical approach.
What this means for your score:
Your Longevity & Healthspan score reflects your aggregate genetic profile across these loci. A higher score indicates a genetic profile more similar to individuals with favorable aging outcomes in the study populations. Because longevity genetics is complex and polygenic, no individual variant or small set of variants fully determines healthspan outcomes — the score represents a directional signal, not a prediction.
Important context: Longevity research at the genomic level is an active and evolving field. The heritability of lifespan is estimated at roughly 25%, meaning the large majority of lifespan variance is attributable to environment, behavior, and chance. Your genetic result is a starting point, not a ceiling.
How Longevity & Healthspan affects you
Your genetic profile for Longevity & Healthspan reflects the aggregate signal from variants at FOXO3, APOE, CHRNA3, CHRNA5, and ATXN2. A higher result indicates a genetic starting point associated with longer, healthier lifespan in population studies. A lower result indicates greater opportunity to use behavioral and environmental levers — which, given the 75% non-genetic contribution to lifespan, remain the dominant determinants of healthspan outcomes for most people.
The biological pathways activated by favorable FOXO3 variants — AMPK signaling, SIRT1 activity, autophagy, DNA repair — are the same pathways activated by caloric restriction, intermittent fasting, aerobic exercise, and adequate sleep. This means that the lifestyle behaviors most strongly associated with longevity in the epidemiological literature are also the behaviors that most directly engage the molecular mechanisms your FOXO3 result reflects.
APOE genotype influences how lipids and cholesterol are managed across decades, with downstream effects on cardiovascular and neurological health — two of the primary organ systems that determine late-life quality of life. CHRNA3/5 variants affect the probability of sustained tobacco exposure, which remains one of the largest single modifiable determinants of lifespan at the population level. ATXN2 contributes to the cellular stress response that underpins neurological resilience across aging.
Working with your Longevity & Healthspan result
The following actions are grounded in the biology of the genes contributing to your result. Each maps to a specific pathway.
Practice time-restricted eating or caloric moderation. Caloric restriction and intermittent fasting are among the most robust activators of FOXO3 via AMPK and SIRT1. A daily eating window of 8-10 hours (time-restricted eating) is a practical, well-studied approach. This directly engages the FOXO3 pathway implicated in your result.
Prioritize regular aerobic exercise. Sustained aerobic activity — particularly zone 2 cardio (conversational pace for 30-45 minutes, 3-5 times per week) — activates AMPK and drives FOXO3 target gene expression, including mitochondrial quality control (BNIP3) and antioxidant defense (MnSOD). Resistance training complements aerobic work by maintaining muscle mass, a strong independent predictor of longevity.
Eliminate tobacco exposure entirely. The CHRNA3/CHRNA5 pathway in your result connects directly to smoking-related healthspan reduction. Regardless of your specific variant profile at this locus, tobacco avoidance is the single highest-impact modifiable behavior for lifespan at the population level. If you smoke, cessation support resources are available through your primary care provider.
Optimize sleep quantity and quality. Sleep is required for neurological autophagy — the brain's waste-clearance process (glymphatic system) is most active during deep sleep. Chronic sleep restriction is associated with accelerated biological aging and impairs the DNA repair and cellular maintenance processes that FOXO3 target genes support.
Adopt a Mediterranean-pattern or whole-food dietary approach. Mediterranean-pattern diets — high in vegetables, legumes, whole grains, olive oil, and fatty fish — are associated with longer healthspan in large epidemiological studies. Omega-3 fatty acids from fatty fish support cardiovascular health, directly relevant to the APOE cardiovascular pathway. Polyphenols from plant foods modulate SIRT1 activity.
Manage psychosocial stress. Chronic psychological stress activates cortisol pathways that suppress FOXO3 activity and accelerate biological aging markers. Structured stress management — mindfulness-based stress reduction, adequate recovery time, social support — maintains the hormonal environment in which FOXO3 and SIRT1 are able to function.
Maintain strong social connections. Social isolation is one of the most consistently replicated non-genetic predictors of premature mortality in large cohort studies, with effect sizes comparable to smoking. Longevity epidemiology consistently identifies strong social connection as a feature of populations with extended healthspan.
Related traits and genes
FOXO3 is the central longevity transcription factor — a gene page with deeper mechanistic detail is available for FOXO3.
Your Longevity & Healthspan result is closely related to several other ExomeDNA traits. Aging Clock reflects a complementary measure of biological age acceleration. Cardiovascular Health shares the APOE pathway and is a primary downstream determinant of longevity outcomes. Alzheimer's Risk is directly shaped by APOE isoform, the same gene contributing to your healthspan result.
Longevity biology also intersects with Sleep Quality — poor sleep accelerates biological aging — and Metabolic Health, given that insulin sensitivity and metabolic flexibility are upstream regulators of the FOXO3 pathway.
Frequently asked questions
See FAQ section below.
References: Timmers PRHJ et al. (2020). Multivariate genomic scan implicates novel loci and haem metabolism in human aging. Nature Communications. PMID 32678081.
ExomeDNA genetic results are for wellness and educational purposes only. Consult a clinician for personalized health guidance.